139 related articles for article (PubMed ID: 8902527)
1. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
Kramer JH; Weglicki WB
Free Radic Biol Med; 1996; 21(6):813-25. PubMed ID: 8902527
[TBL] [Abstract][Full Text] [Related]
2. Magnesium-deficiency potentiates free radical production associated with postischemic injury to rat hearts: vitamin E affords protection.
Kramer JH; Misík V; Weglicki WB
Free Radic Biol Med; 1994 Jun; 16(6):713-23. PubMed ID: 8070674
[TBL] [Abstract][Full Text] [Related]
3. Postischemic free radical production in the venous blood of the regionally ischemic swine heart. Effect of deferoxamine.
Mergner GW; Weglicki WB; Kramer JH
Circulation; 1991 Nov; 84(5):2079-90. PubMed ID: 1657449
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.
Khandoudi N; Percevault-Albadine J; Bril A
J Cardiovasc Pharmacol; 1998 Sep; 32(3):443-51. PubMed ID: 9733358
[TBL] [Abstract][Full Text] [Related]
5. Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade.
Kramer JH; Phillips TM; Weglicki WB
J Mol Cell Cardiol; 1997 Jan; 29(1):97-110. PubMed ID: 9040025
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
[TBL] [Abstract][Full Text] [Related]
7. PBN spin trapping of free radicals in the reperfusion-injured heart. Limitations for pharmacological investigations.
Vrbjar N; Zöllner S; Haseloff RF; Pissarek M; Blasig IE
Mol Cell Biochem; 1998 Sep; 186(1-2):107-15. PubMed ID: 9774191
[TBL] [Abstract][Full Text] [Related]
8. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
9. Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress.
Kramer JH; Mak IT; Phillips TM; Weglicki WB
Exp Biol Med (Maywood); 2003 Jun; 228(6):665-73. PubMed ID: 12773697
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
12. Lack of protection of PBN in isolated heart during ischemia and reperfusion: implications for radical scavenging mechanism.
Baker JE; Konorev EA; Tse SY; Joseph J; Kalyanaraman B
Free Radic Res; 1994 Mar; 20(3):145-63. PubMed ID: 8019639
[TBL] [Abstract][Full Text] [Related]
13. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
[TBL] [Abstract][Full Text] [Related]
15. Mg-gluconate provides superior protection against postischemic dysfunction and oxidative injury compared to Mg-sulfate.
Murthi SB; Wise RM; Weglicki WB; Komarov AM; Kramer JH
Mol Cell Biochem; 2003 Mar; 245(1-2):141-8. PubMed ID: 12708753
[TBL] [Abstract][Full Text] [Related]
16. Isolated perfused rat hearts release secondary free radicals during ischemia reperfusion injury: cardiovascular effects of the spin trap alpha-phenyl N-tert-butylnitrone.
Vergely C; Tabard A; Maupoil V; Rochette L
Free Radic Res; 2001 Nov; 35(5):475-89. PubMed ID: 11767406
[TBL] [Abstract][Full Text] [Related]
17. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.
Santos DJ; Moreno AJ
Biochem Pharmacol; 2001 Jan; 61(2):155-64. PubMed ID: 11163330
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
[TBL] [Abstract][Full Text] [Related]
20. Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injury.
Christopher TA; Lopez BL; Ma XL; Feuerstein GZ; Ruffolo RR; Yue TL
Br J Pharmacol; 1998 Jan; 123(2):292-8. PubMed ID: 9489618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
